What is your current role in EPAD? As a Data Scientist at Aridhia, I support the development and maintenance of the Analytical Database for the EPAD Longitudinal Cohort Study. IQVIA securely transfer the collated project data from their EDC platform (Medidata Rave) to our digital research platform (AnalytiXagility) on a regular basis. We transform the…
Dr Vanessa Raymont (pictured) is a senior researcher and consultant psychiatrist working in the Department of Psychiatry at the University of Oxford and the Centre for Dementia Prevention at the University of Edinburgh. She is also a lead researcher for the EPAD project in Oxford. She was recently interviewed by Elder online magazine about assessing…
Summary: Biomedical research aimed at the development of therapies for chronic and late‐onset conditions increasingly concentrates on the early treatment of symptom‐less disease. This broad trend is evidenced in prominent shifts in contemporary dementia research. Revised diagnostic criteria and new approaches to clinical trials propose a focus on earlier stages of disease and prompt concerns…
We are delighted to announce that March was the most successful month to date with 66 new research participants enrolled in the EPAD Longitudinal Cohort Study. The month of March was a fantastic month for the EPAD study and exceeded the mark set in February with 53 research participants recruited. It is the second time…
On 22 March, The Lancet Neurology published an article entitled: “Frederik Barkhof: building bridges between disciplines” where EPAD and its sister project AMYPAD were featured. In this great article, Professor Frederik Barkhof, AMYPAD coordinator and member of the EPAD imaging scientific advisory group, was interviewed to share his early academic journey. The article can be downloaded…
The IMI-EMIF initiative would like to invite you to its public symposium: ‘Liberating Evidence from European Health Data – the Achievements and Challenges of a Five Year IMI Project: EMIF’ that is to be held on the 18th of April 2018 at Hotel Bloom, Brussels, Belgium. This meeting will bring together a large variety of stakeholders to discuss…
We are very pleased to announce that the Barcelonabeta Brain Research Center (BBRC) was the most successful trial delivery centre (TDC) in February with 14 newly screened participants in the EPAD Longitudinal Cohort Study (LCS). Congratulations to the entire team (pictured)! The European Prevention of Alzheimer’s Dementia initiative (EPAD) recruited its first Spanish research participant…
Summary: In clinical trials which target pathophysiological mechanisms associated with Alzheimer’s disease, research participants who are recruited based on biomarker test results should be informed about their increased risk of developing Alzheimer’s dementia. This paper presents the results of a qualitative focus group study of attitudes and concerns toward learning information about biomarker-based risk…
On 27 February, our partner Alzheimer Europe (AE) held a successful lunch debate entitled “Will we be able to prevent Alzheimer’s dementia” at the European Parliament in Brussels (Belgium). The lunch debate focused on the prevention of Alzheimer’s disease (AD) and dementia through three key presentations. The panel included a presentation by the European Prevention…
The EPAD Academy core team encourages the EPAD Fellows to present their work at national and international scientific conferences and events. To highlight the importance of presenting young researchers’ work, awards are now given for the best poster presentations. Each EPAD Fellows could enter the competition. They are inviting to share photos of theirs…
